Zaeem Siddiqi and Derrick Blackmore, University of Alberta Faculty of Medicine & Dentistry (IMAGE)

University of Alberta Faculty of Medicine & Dentistry

Zaeem Siddiqi and Derrick Blackmore, University of Alberta Faculty of Medicine & Dentistry

Caption

U of A researchers Zaeem Siddiqi (left) and Derrick Blackmore pinpointed 12 metabolic byproducts that only appear in people with myasthenia gravis -- a biological marker that will improve diagnosis and allow for personalized treatments for the rare autoimmune disease.

Credit

Ryan O'Byrne

Usage Restrictions

May be used with appropriate credit

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.